Page 19 - Astrazeneca

AstraZeneca Pharma gets nod from drug regulator to market asthma medicine

AstraZeneca Pharma said it has received marketing authorisation from Drug Controller General of India for Benralizumab solution, indicated as an add-on maintenance treatment for severe asthma

Serum Institute to seek nod for two full-dose regimen of Covishield

Suresh Jadhav, executive director of the Pune-based firm, said on Friday Serum was seeking approval from the Drug Controller General of India (DCGI) for the two-full dose regimen

COVAX gains access to 2 billion doses of vaccines for 190 member economies

First deliveries are expected to begin in the first quarter of 2021 depending upon regulatory approvals and readiness of countries for delivery

Despite heroic work for Covid vaccine, pharma cos don't deserve affection

A financial analyst recently told that Pfizer's involvement in the coronavirus pandemic was about "as much public relations as it is a financial return

States told to estimate and strengthen cold chain for vaccine: Health secy

In all, 29,000 cold chain points, 240 walk-in coolers, 70 walk-in freezers, 45,000 ice-lined refrigerators, 41,000 deep freezers and 300 solar refrigerators are to be used

Stuck in Sydney hotel, Astra CEO defended Covid vaccine and made mega deal

AstraZeneca announced Saturday it plans to buy rare-disease specialist Alexion Pharmaceuticals in a $39 billion deal

Covid-19 vaccines raise hope for cancer, throw open new field of medicine

Approach used by Moderna. and Pfizer, BioNTech SE partnership have never been used outside of clinical experiments.

AstraZeneca to buy Alexion for $39 billion to expand in immunology

AstraZeneca is one of the frontrunners in the drugs industry's search for a Covid-19 vaccine

AstraZeneca to test combining Covid-19 vaccine with Russian shot

Trials to start by the end of the year

Kiran Mazumdar-Shaw: Will take Covid vaccine; confident on safety, efficacy

Bharat Biotech, Serum Institute of India and Pfizer have applied to the Drugs Controller General of India seeking emergency use authorisation for their Covid-19 vaccine candidates

AstraZeneca's Covid-19 vaccine 70.4% effective at preventing the infection

AstraZeneca's Covid-19 vaccine is safe and effective at preventing symptomatic infection and it protects against severe disease and hospitalisation, a study concluded

US Astra Covid-19 vaccine trial will tell how well it works: Top scientist

A top US scientist overseeing Covid-19 vaccine trials expects a large US study to determine how effective AstraZeneca's experimental inoculation is

Decoded: What emergency use authorisation of Covid vaccine means for us

After the Indian arm of US pharmaceutical giant Pfizer, the Serum Institute of India has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation

AstraZeneca, Qure.ai to bring AI solutions to detect lung cancer

The partnership aims to harness and scale-up the use of this technology to improve early-stage detection of lung cancer in the markets involved, to reduce mortality rates and improve patient outcomes.

India weighing quick emergency review of Pfizer, AstraZeneca vaccines

Serum Institute is making AstraZeneca's Covid-19 vaccine in India and has applied for emergency use authorisation.

Fortune or foresight? AstraZeneca, Oxford stories clash on Covid-19 vaccine

The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose

Brazil to get 15 mn doses of Oxford-AstraZeneca Covid-19 vaccine in Jan-Feb

The first batch of 15 million doses of Oxford University and AstraZeneca's coronavirus vaccine will be shipped to Brazil in January and February, Health Minister Eduardo Pazuello said

AstraZeneca data, NovaVax delay spur Moderna Covid vaccine demand, says CEO

He also said that the higher efficacy rate "was in people younger than 55 years old."

AstraZeneca partner sticks with 2 full dose regimen in India Covid trials

The British drugmaker has said its COVID-19 vaccine could be up to 90% effective if administered as a half dose followed by a full dose

AstraZeneca sells cholesterol drug rights to Grünenthal for $320 million

AstraZeneca aims to streaming its businesses to focus on its cancer portfolio.